| # | Drug | Count |
|---|---|---|
| 0 | MISOPROSTOL | 157 |
| 1 | LEVONORGESTREL | 127 |
| 2 | COPPER | 78 |
| 3 | DOXYCYCLINE | 56 |
| 4 | DOXYCYCLINE HYCLATE | 55 |
| 5 | METRONIDAZOLE | 28 |
| 6 | MIFEPRISTONE | 28 |
| 7 | METRONIDAZOLE TOPICAL | 24 |
| 8 | ERGOCALCIFEROL | 19 |
| 9 | FOLIC ACID | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MISOPROSTOL | 157 | 0.0161 |
| 1 | MIFEPRISTONE | 28 | 0.0059 |
| 2 | OXYTOCIN | 15 | 0.0049 |
| 3 | DINOPROSTONE | 2 | 0.0024 |
| 4 | PILOCARPINE HYDROCHLORIDE | 6 | 0.0024 |
| 5 | DROSPIRENONE AND ESTRADIOL | 1 | 0.0019 |
| 6 | COPPER | 78 | 0.0018 |
| 7 | EPINASTINE HYDROCHLORIDE | 2 | 0.0018 |
| 8 | ELAGOLIX AND ESTRADIOL AND NORETHISTERONE | 1 | 0.0017 |
| 9 | FERROUS ASPARTO GLYCINATE, IRON, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN, ZINC, AND SUCCINIC ACID | 1 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostaglandin E1 Analog [EPC] | 157 |
| 1 | Progestin [EPC] | 136 |
| 2 | Progestin-containing Intrauterine System [EPC] | 127 |
| 3 | Copper-containing Intrauterine Device [EPC] | 78 |
| 4 | Tetracycline-class Drug [EPC] | 55 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 38 |
| 6 | Corticosteroid [EPC] | 36 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 29 |
| 8 | Nitroimidazole Antimicrobial [EPC] | 28 |
| 9 | Progestin Antagonist [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostaglandin E1 Analog [EPC] | 157 | 0.0095 |
| 1 | Progestin Antagonist [EPC] | 28 | 0.0059 |
| 2 | Oxytocic [EPC] | 15 | 0.0049 |
| 3 | Copper-containing Intrauterine Device [EPC] | 78 | 0.0016 |
| 4 | Tetracycline-class Drug [EPC] | 55 | 0.0008 |
| 5 | Provitamin D2 Compound [EPC] | 19 | 0.0006 |
| 6 | Sodium Channel Blocker [EPC] | 1 | 0.0006 |
| 7 | Progestin [EPC] | 136 | 0.0005 |
| 8 | Nitroimidazole Antimicrobial [EPC] | 28 | 0.0004 |
| 9 | Anthelmintic [EPC] | 1 | 0.0003 |